AngioDynamics Inc. (NASDAQ: ANGO) is -36.85% lower on its value in year-to-date trading and has touched a low of $7.48 and a high of $22.09 in the current 52-week trading range. The ANGO stock was last observed hovering at around $10.17 in the last trading session, with the day’s loss setting it -0.06% off its average median price target of $14.00 for the next 12 months. It is also 27.79% off the consensus price target high of $14.00 offered by analysts, but current levels are 27.79% higher than the price target low of $14.00 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $10.11, the stock is -2.85% and -3.06% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.16 million and changing -0.59% at the moment leaves the stock -22.54% off its SMA200. ANGO registered -49.58% loss for a year compared to 6-month loss of -36.85%. The firm has a 50-day simple moving average (SMA 50) of $10.46 and a 200-day simple moving average (SMA200) of $11.78.
The stock witnessed a 0.20% gain in the last 1 month and extending the period to 3 months gives it a 4.77%, and is 5.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.46% over the week and 6.01% over the month.
AngioDynamics Inc. (ANGO) has around 750 employees, a market worth around $379.93M and $255.60M in sales. Fwd P/E is 94.49. Distance from 52-week low is 35.16% and -54.23% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.80%).
AngioDynamics Inc. (ANGO) Analyst Forecasts
AngioDynamics Inc. quarterly earnings per share for the current quarter are estimated at -$0.06 with sales reaching $68.22M over the same period.The EPS is expected to grow by 19.10% this year, but quarterly earnings will post -25.30% year-over-year. Quarterly sales are estimated to shrink -29.20% in year-over-year returns.
AngioDynamics Inc. (ANGO) Top Institutional Holders
240 institutions hold shares in AngioDynamics Inc. (ANGO), with 1.16M shares held by insiders accounting for 3.08% while institutional investors hold 103.64% of the company’s shares. The shares outstanding are 38.00M, and float is at 36.54M with Short Float at 2.47%. Institutions hold 100.45% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 6.2 million shares valued at $64.63 million. The investor’s holdings represent 16.44% of the ANGO Shares outstanding. As of Mar 30, 2020, the second largest holder is Victory Capital Management Inc. with 4.8 million shares valued at $50.09 million to account for 12.74% of the shares outstanding. The other top investors are Dimensional Fund Advisors LP which holds 3.13 million shares representing 8.30% and valued at over $32.64 million, while Vanguard Group, Inc. (The) holds 6.33% of the shares totaling 2.38 million with a market value of $24.87 million.
AngioDynamics Inc. (ANGO) Insider Activity
A total of 5 insider transactions have happened at AngioDynamics Inc. (ANGO) in the last six months, with sales accounting for 4 and purchases happening 1 times. The most recent transaction is an insider purchase by Clemmer James C, the company’s President and CEO. SEC filings show that Clemmer James C bought 15,000 shares of the company’s common stock on Oct 25 at a price of $14.19 per share for a total of $0.21 million. Following the purchase, the insider now owns 0.26 million shares.
AngioDynamics Inc. disclosed in a document filed with the SEC on Jul 16 that Gould Kevin J (Director) sold a total of 13,650 shares of the company’s common stock. The trade occurred on Jul 16 and was made at $21.45 per share for $0.29 million. Following the transaction, the insider now directly holds 55124.0 shares of the ANGO stock.
AngioDynamics Inc. (ANGO): Who are the competitors?
The company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 0.25% up over the past 12 months. LeMaitre Vascular Inc. (LMAT) is -6.79% down on the 1-year trading charts. Short interest in the company’s stock has fallen -17.23% from the last report on May 14, 2020 to stand at a total of 1.06 million short shares sold with a short interest ratio of 3.37.